Nutritional and metabolic status of children with autism vs. neurotypical children, and the association with autism severity

<p>Abstract</p> <p>Background</p> <p>The relationship between relative metabolic disturbances and developmental disorders is an emerging research focus. This study compares the nutritional and metabolic status of children with autism with that of neurotypical children a...

Full description

Bibliographic Details
Main Authors: Gehn Eva, Geis Elizabeth, Quig David, Rubin Robert A, McDonough-Means Sharon, Audhya Tapan, Adams James B, Loresto Melissa, Mitchell Jessica, Atwood Sharon, Barnhouse Suzanne, Lee Wondra
Format: Article
Language:English
Published: BMC 2011-06-01
Series:Nutrition & Metabolism
Online Access:http://www.nutritionandmetabolism.com/content/8/1/34
id doaj-f056079b857f465b9f41c426738e4a18
record_format Article
spelling doaj-f056079b857f465b9f41c426738e4a182020-11-24T21:27:40ZengBMCNutrition & Metabolism1743-70752011-06-01813410.1186/1743-7075-8-34Nutritional and metabolic status of children with autism vs. neurotypical children, and the association with autism severityGehn EvaGeis ElizabethQuig DavidRubin Robert AMcDonough-Means SharonAudhya TapanAdams James BLoresto MelissaMitchell JessicaAtwood SharonBarnhouse SuzanneLee Wondra<p>Abstract</p> <p>Background</p> <p>The relationship between relative metabolic disturbances and developmental disorders is an emerging research focus. This study compares the nutritional and metabolic status of children with autism with that of neurotypical children and investigates the possible association of autism severity with biomarkers.</p> <p>Method</p> <p>Participants were children ages 5-16 years in Arizona with Autistic Spectrum Disorder (n = 55) compared with non-sibling, neurotypical controls (n = 44) of similar age, gender and geographical distribution. Neither group had taken any vitamin/mineral supplements in the two months prior to sample collection. Autism severity was assessed using the Pervasive Development Disorder Behavior Inventory (PDD-BI), Autism Treatment Evaluation Checklist (ATEC), and Severity of Autism Scale (SAS). Study measurements included: vitamins, biomarkers of vitamin status, minerals, plasma amino acids, plasma glutathione, and biomarkers of oxidative stress, methylation, sulfation and energy production.</p> <p>Results</p> <p>Biomarkers of children with autism compared to those of controls using a t-test or Wilcoxon test found the following statistically significant differences (p < 0.001): Low levels of biotin, plasma glutathione, RBC SAM, plasma uridine, plasma ATP, RBC NADH, RBC NADPH, plasma sulfate (free and total), and plasma tryptophan; also high levels of oxidative stress markers and plasma glutamate. Levels of biomarkers for the neurotypical controls were in good agreement with accessed published reference ranges. In the Autism group, mean levels of vitamins, minerals, and most amino acids commonly measured in clinical care were within published reference ranges.</p> <p>A stepwise, multiple linear regression analysis demonstrated significant associations between several groups of biomarkers with all three autism severity scales, including vitamins (adjusted R<sup>2 </sup>of 0.25-0.57), minerals (adj. R<sup>2 </sup>of 0.22-0.38), and plasma amino acids (adj. R<sup>2 </sup>of 0.22-0.39).</p> <p>Conclusion</p> <p>The autism group had many statistically significant differences in their nutritional and metabolic status, including biomarkers indicative of vitamin insufficiency, increased oxidative stress, reduced capacity for energy transport, sulfation and detoxification. Several of the biomarker groups were significantly associated with variations in the severity of autism. These nutritional and metabolic differences are generally in agreement with other published results and are likely amenable to nutritional supplementation. Research investigating treatment and its relationship to the co-morbidities and etiology of autism is warranted.</p> http://www.nutritionandmetabolism.com/content/8/1/34
collection DOAJ
language English
format Article
sources DOAJ
author Gehn Eva
Geis Elizabeth
Quig David
Rubin Robert A
McDonough-Means Sharon
Audhya Tapan
Adams James B
Loresto Melissa
Mitchell Jessica
Atwood Sharon
Barnhouse Suzanne
Lee Wondra
spellingShingle Gehn Eva
Geis Elizabeth
Quig David
Rubin Robert A
McDonough-Means Sharon
Audhya Tapan
Adams James B
Loresto Melissa
Mitchell Jessica
Atwood Sharon
Barnhouse Suzanne
Lee Wondra
Nutritional and metabolic status of children with autism vs. neurotypical children, and the association with autism severity
Nutrition & Metabolism
author_facet Gehn Eva
Geis Elizabeth
Quig David
Rubin Robert A
McDonough-Means Sharon
Audhya Tapan
Adams James B
Loresto Melissa
Mitchell Jessica
Atwood Sharon
Barnhouse Suzanne
Lee Wondra
author_sort Gehn Eva
title Nutritional and metabolic status of children with autism vs. neurotypical children, and the association with autism severity
title_short Nutritional and metabolic status of children with autism vs. neurotypical children, and the association with autism severity
title_full Nutritional and metabolic status of children with autism vs. neurotypical children, and the association with autism severity
title_fullStr Nutritional and metabolic status of children with autism vs. neurotypical children, and the association with autism severity
title_full_unstemmed Nutritional and metabolic status of children with autism vs. neurotypical children, and the association with autism severity
title_sort nutritional and metabolic status of children with autism vs. neurotypical children, and the association with autism severity
publisher BMC
series Nutrition & Metabolism
issn 1743-7075
publishDate 2011-06-01
description <p>Abstract</p> <p>Background</p> <p>The relationship between relative metabolic disturbances and developmental disorders is an emerging research focus. This study compares the nutritional and metabolic status of children with autism with that of neurotypical children and investigates the possible association of autism severity with biomarkers.</p> <p>Method</p> <p>Participants were children ages 5-16 years in Arizona with Autistic Spectrum Disorder (n = 55) compared with non-sibling, neurotypical controls (n = 44) of similar age, gender and geographical distribution. Neither group had taken any vitamin/mineral supplements in the two months prior to sample collection. Autism severity was assessed using the Pervasive Development Disorder Behavior Inventory (PDD-BI), Autism Treatment Evaluation Checklist (ATEC), and Severity of Autism Scale (SAS). Study measurements included: vitamins, biomarkers of vitamin status, minerals, plasma amino acids, plasma glutathione, and biomarkers of oxidative stress, methylation, sulfation and energy production.</p> <p>Results</p> <p>Biomarkers of children with autism compared to those of controls using a t-test or Wilcoxon test found the following statistically significant differences (p < 0.001): Low levels of biotin, plasma glutathione, RBC SAM, plasma uridine, plasma ATP, RBC NADH, RBC NADPH, plasma sulfate (free and total), and plasma tryptophan; also high levels of oxidative stress markers and plasma glutamate. Levels of biomarkers for the neurotypical controls were in good agreement with accessed published reference ranges. In the Autism group, mean levels of vitamins, minerals, and most amino acids commonly measured in clinical care were within published reference ranges.</p> <p>A stepwise, multiple linear regression analysis demonstrated significant associations between several groups of biomarkers with all three autism severity scales, including vitamins (adjusted R<sup>2 </sup>of 0.25-0.57), minerals (adj. R<sup>2 </sup>of 0.22-0.38), and plasma amino acids (adj. R<sup>2 </sup>of 0.22-0.39).</p> <p>Conclusion</p> <p>The autism group had many statistically significant differences in their nutritional and metabolic status, including biomarkers indicative of vitamin insufficiency, increased oxidative stress, reduced capacity for energy transport, sulfation and detoxification. Several of the biomarker groups were significantly associated with variations in the severity of autism. These nutritional and metabolic differences are generally in agreement with other published results and are likely amenable to nutritional supplementation. Research investigating treatment and its relationship to the co-morbidities and etiology of autism is warranted.</p>
url http://www.nutritionandmetabolism.com/content/8/1/34
work_keys_str_mv AT gehneva nutritionalandmetabolicstatusofchildrenwithautismvsneurotypicalchildrenandtheassociationwithautismseverity
AT geiselizabeth nutritionalandmetabolicstatusofchildrenwithautismvsneurotypicalchildrenandtheassociationwithautismseverity
AT quigdavid nutritionalandmetabolicstatusofchildrenwithautismvsneurotypicalchildrenandtheassociationwithautismseverity
AT rubinroberta nutritionalandmetabolicstatusofchildrenwithautismvsneurotypicalchildrenandtheassociationwithautismseverity
AT mcdonoughmeanssharon nutritionalandmetabolicstatusofchildrenwithautismvsneurotypicalchildrenandtheassociationwithautismseverity
AT audhyatapan nutritionalandmetabolicstatusofchildrenwithautismvsneurotypicalchildrenandtheassociationwithautismseverity
AT adamsjamesb nutritionalandmetabolicstatusofchildrenwithautismvsneurotypicalchildrenandtheassociationwithautismseverity
AT lorestomelissa nutritionalandmetabolicstatusofchildrenwithautismvsneurotypicalchildrenandtheassociationwithautismseverity
AT mitchelljessica nutritionalandmetabolicstatusofchildrenwithautismvsneurotypicalchildrenandtheassociationwithautismseverity
AT atwoodsharon nutritionalandmetabolicstatusofchildrenwithautismvsneurotypicalchildrenandtheassociationwithautismseverity
AT barnhousesuzanne nutritionalandmetabolicstatusofchildrenwithautismvsneurotypicalchildrenandtheassociationwithautismseverity
AT leewondra nutritionalandmetabolicstatusofchildrenwithautismvsneurotypicalchildrenandtheassociationwithautismseverity
_version_ 1725974172395372544